LED Light Source Colibri.2 – Higher Light Intensity and New Wavelengths
March 29, 2011
GOETTINGEN/Germany - Introducing Colibri.2 Carl Zeiss now offers now an improved LED light source for fluorescence microscopy. Colibri.2 is adaptable to a majority of microscopes and is easily controlled in the AxioVision software. A multitude of different experiments can be effortlessly designed and executed by using Colibri.2, even when precise timing for extremely fast acquisition. [...]
March 29, 2011
WALTHAM, MA – PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a new oncology testing service. The new service utilizes OncoChip™, a new microarray technology to aid in faster, earlier and more accurate diagnoses of hematological malignancies. The OncoChip technology assists physicians [...]
Thermo Fisher Scientific Launches New Near-infrared Spectrometer for Pharmaceutical Processing
March 29, 2011
WILMINGTON, Mass. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific TruProcess analyzer, the next-generation near-infrared (NIR) spectrometer for real-time blend analysis, drying and other process analytical technology (PAT) applications. The TruProcess™ analyzer demonstrates the proven precision of a benchtop system and is easily integrated into existing [...]
Avacta Analytical Signs Exclusive Distribution Agreement with DKSH Japan
March 29, 2011
Avacta Group plc (AIM:AVCT), the provider of innovative, high value proprietary technologies and services to the pharmaceutical and diagnostics markets is pleased to announce that it has signed an exclusive agreement for the distribution of Optim, the market leading low volume protein analysis system, with DKSH Japan ("DKSH"), the leading Market Expansion Services Group with [...]
March 29, 2011
SAN DIEGO - Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture. As a key element of the company’s strategy for optimizing the R&D value chain, the suite offers a unique platform approach to scientific [...]
March 29, 2011
AMSBIO has announced, as of 31st March 2011, the opening of a new North American subsidiary company - AMSBIO LLC**. After successfully selling innovative life science technologies, biotools and services directly to North American researchers, the new office will be a fully integrated entity supporting the AMSBIO product line with a dedicated sales and service [...]
UPDATE FROM AGILENT TECHNOLOGIES JAPAN: Status of Operations Following Earthquake and Tsunami
March 29, 2011
OKYO - Agilent employees and facilities were unaffected by the March 11 earthquake and tsunami, and Agilent in Japan is now operational. However, due to planned power outages by Tokyo Electric Power Company, Agilent's Hachioji operations are fluctuating. The company is working on alternative processes to best serve its customers and cause the least amount [...]
March 29, 2011
SANTA CLARA, Calif. and SINGAPORE - Agilent Technologies Inc. (NYSE: A) and the National University of Singapore (NUS) today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states. Under the terms [...]
ITT Analytics Launches the New SI Analytics TitroLine® Titrator Series
March 28, 2011
WHITE PLAINS, NY. - ITT Corporation (NYSE:ITT) announced that its SI Analytics brand has launched the TitroLine® titrator series for advanced titration and dosing applications. This series completes SI Analytics’ offering of automatic titrators and includes the TitroLine® 6000, TitroLine® 7000 and TITRONIC® 500 piston burette. The family of instruments combines accuracy and ease-of-use to [...]
March 28, 2011
CAMBRIDGE, Mass. - Selventa™ today announced a continuation and expansion of its strategic partnership with the world’s largest pharmaceutical company, Pfizer Inc., in the areas of biological knowledge dissemination and drug safety. The scope of the new collaboration, co-funded by Pfizer, includes creating a publicly available version of Selventa’s Biological Expression Language (BEL) and associated [...]
